Our current results show that baseline STAT6 and STAT1 phosphorylation levels in circulating leukocytes are associated with treatment response to synthetic DMARDs and biologicals in RA, and that their ratio is influenced by the treatments. Here, STAT1 is linked to rheumatoid arthritis.